Healthcare Banner

Latest Market Reports in Healthcare

Japan Haemophilus Influenzae Type B Vaccine Market, By Type (Type1-HIB Vaccine and Type 2-DTaP-IPV); By Formulation (Liquid Monovalent HIB, Liquid Combination HIB, Lyophilized Monovalent HIB and Lyophilized Combination HIB); By Application (Hospitals, Research & Academic Labs, Pharmaceuticals and Biotechnology Companies and Others) — Market Size and Forecasting to 2030

The Japan Haemophilus Influenzae Type B Vaccine Market report includes a regional opportunity analysis and industry forecasts for the period 2021-2030. The market was valued at USD xx. xx billion in 2020 and is expected to reach USD xx. xx billion by 2030, registering a CAGR of xx. xx% from 2021 to 2030. The base year considered for the study is 2020, and the forecast has been provided for the period, 2021 to 2030.

Japan Elastomeric Infusion Pumps Market, By Product (Continuous Rate Elastomeric Pumps and Variable Rate Elastomeric Pumps); By Application (Pain Management, Infection Management, Chemotherapy and Others); By Route of Administration (Intravenous, Intra-Arterial, Subcutaneous, Epidural and Intramuscular); By End User (Hospitals, Ambulatory Surgical Centers, Clinics, Home Care and Others) — Market Size and Forecasting to 2030

The Japan Elastomeric Infusion Pumps Market report includes a regional opportunity analysis and industry forecasts for the period 2021-2030. The market was valued at USD xx. xx billion in 2020 and is expected to reach USD xx. xx billion by 2030, registering a CAGR of xx. xx% from 2021 to 2030. The base year considered for the study is 2020, and the forecast has been provided for the period, 2021 to 2030.

Japan Polycystic Ovary Syndrome Treatment Market, By Drugs (Oral Contraceptives, Insulin-Sensitizing Drugs, Antidepressants, Anti-Androgen Drugs and Others); By Surgery (Laparoscopic Ovarian Drilling and Ovarian Wedge Resection); By Distribution Channel (Online and Offline) — Market Size and Forecasting to 2030

The Japan Polycystic Ovary Syndrome Treatment Market report includes a regional opportunity analysis and industry forecasts for the period 2021-2030. The market was valued at USD xx. xx billion in 2020 and is expected to reach USD xx. xx billion by 2030, registering a CAGR of xx. xx% from 2021 to 2030. The base year considered for the study is 2020, and the forecast has been provided for the period, 2021 to 2030.

Japan Structural Heart Devices Market, By Product (Heart Valves, Occluders, Annuloplasty Rings, Accessories and Others); By Procedure (Replacement and Repair); By Indication (Cardiomyopathy, Valvular Heart Disease, Congenital Heart Defects and Others) — Market Size and Forecasting to 2030

The Japan Structural Heart Devices Market report includes a regional opportunity analysis and industry forecasts for the period 2021-2030. The market was valued at USD xx. xx billion in 2020 and is expected to reach USD xx. xx billion by 2030, registering a CAGR of xx. xx% from 2021 to 2030. The base year considered for the study is 2020, and the forecast has been provided for the period, 2021 to 2030.

Japan Cochlear Implants Market, By Product (Unilateral Implants and Bilateral Implants); By End User (Adults and Children) — Market Size and Forecasting to 2030

The Japan Cochlear Implants Market report includes a regional opportunity analysis and industry forecasts for the period 2021-2030. The market was valued at USD xx. xx billion in 2020 and is expected to reach USD xx. xx billion by 2030, registering a CAGR of xx. xx% from 2021 to 2030. The base year considered for the study is 2020, and the forecast has been provided for the period, 2021 to 2030.

Japan Huntington’s Disease Treatment Market, By Drug (Tetrabenazine, Antidepressants, Antipsychotic Drugs, Tranquilizers and Others); By Distribution Channel (Online and Offline) — Market Size and Forecasting to 2030

The Japan Huntington’s Disease Treatment Market report includes a regional opportunity analysis and industry forecasts for the period 2021-2030. The market was valued at USD xx. xx billion in 2020 and is expected to reach USD xx. xx billion by 2030, registering a CAGR of xx. xx% from 2021 to 2030. The base year considered for the study is 2020, and the forecast has been provided for the period, 2021 to 2030.

Japan Dermal Fillers Market, By Ingredient (Hyaluronic Acid, Calcium Hydroxylapatite, Collagen, Poly-L-Lactic Acid, PMMA [Poly Methyl Methacrylate] and Others); By Product (Biodegradable and Non-Biodegradable); By Application (Lip Enhancement, Wrinkle Correction Treatment, Face-Lift, Scar Treatment and Others) — Market Size and Forecasting to 2030

The Japan Dermal Fillers Market report includes a regional opportunity analysis and industry forecasts for the period 2021-2030. The market was valued at USD xx. xx billion in 2020 and is expected to reach USD xx. xx billion by 2030, registering a CAGR of xx. xx% from 2021 to 2030. The base year considered for the study is 2020, and the forecast has been provided for the period, 2021 to 2030.

Japan Alzheimer’s Treatment Market, By Drug Class (Standalone Drugs [Cholinesterase Inhibitors and N-Methyl-D-Aspartate Antagonist] and Combination Drugs); By Distribution Channel (Offline [Hospital Pharmacy and Retail Pharmacy] and Online); By Product (Wearable and Non-Wearable); By End User (Hospitals, Clinics, Nursing Homes and Home-Care Settings) — Market Size and Forecasting to 2030

The Japan Alzheimer’s Treatment Market report includes a regional opportunity analysis and industry forecasts for the period 2021-2030. The market was valued at USD xx. xx billion in 2020 and is expected to reach USD xx. xx billion by 2030, registering a CAGR of xx. xx% from 2021 to 2030. The base year considered for the study is 2020, and the forecast has been provided for the period, 2021 to 2030.

Japan Pulmonary Fibrosis Drugs Market, By Drug (Pirfenidone and Nintedanib) — Market Size and Forecasting to 2030

The Japan Pulmonary Fibrosis Drugs Market report includes a regional opportunity analysis and industry forecasts for the period 2021-2030. The market was valued at USD xx. xx billion in 2020 and is expected to reach USD xx. xx billion by 2030, registering a CAGR of xx. xx% from 2021 to 2030. The base year considered for the study is 2020, and the forecast has been provided for the period, 2021 to 2030.

Japan Antidepressant Drugs Market, By Drug Class (Serotonin and Noradrenaline Reuptake Inhibitors [SNRIs], Selective Serotonin Reuptake Inhibitors [SSRIs], Tricyclic Antidepressants [TCAs], Monoamine Oxidase Inhibitors [MAOIs], Noradrenaline and Specific Serotoninergic Antidepressants [NASSAs] and Others); By Depressive Disorder (Major Depressive Disorder, Generalized Anxiety Disorder, Obsessive Compulsive Disorder, Panic Disorder) — Market Size and Forecasting to 2030

The Japan Antidepressant Drugs Market report includes a regional opportunity analysis and industry forecasts for the period 2021-2030. The market was valued at USD xx. xx billion in 2020 and is expected to reach USD xx. xx billion by 2030, registering a CAGR of xx. xx% from 2021 to 2030. The base year considered for the study is 2020, and the forecast has been provided for the period, 2021 to 2030.